Axsome Therapeutics Hosts Sunosi® Investor Update Virtual

NEW YORK, June 28, 2022 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel...

Related Keywords

China ,Japan ,United States ,Stephenv Faraone ,Richardk Bogan ,Andrew Krystal ,Sk Biopharmaceuticals Co Ltd ,Axsome Therapeutics Inc ,Drug Administration ,Continuous Positive Airway Pressure ,Department Of Psychiatry ,Nasdaq ,Us Drug Enforcement Agency On ,Airway Pressure ,University Of South Carolina School Medicine ,Weill Institute For Neurosciences ,Key Opinion Leaders ,Bogan Sleep Consultants ,Associate Clinical Professor ,South Carolina School ,Medical University ,Dagmar Dolby Distinguished Professor ,Distinguished Professor ,Enforcement Agency ,Full Prescribing Information ,Medication Guide ,Prescribing Information ,Obstructive Sleep Apnea ,Excessive Daytime ,Axsome Therapeutics ,Nasdaq Axsm ,Nc ,Vsunosi ,Axsm ,Ns ,Narcolepsy ,Sa ,Ads ,